Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=95

Publishing Process of This Article

Item

Count

Browse

Download

Sum=1

Feb 27, 2025 (publication date) through Feb 23, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Hepatol. Feb 27, 2025; 17(2): 101165
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101165

Table 1 Classification of myokines according to their effects on muscle growth, differentiation and repair

Positive regulators	Negative regulators
Irisin	Growth differentiation factor 8 (myostatin)
Insulin growth factor 1	Transforming growth factor β
Follistatin	Activins
Bone-morphogenic proteins	-
Brain-derived neurotrophic factor	-
Meteorin like factor (metrnl)	-
Fibroblast growth factor 21	-
Β-aminoisobutyric acid	-
Apelin	-
Interleukin 10	Interleukin 6
Interleukin 15	-

Citation: Al-Nimer MS. Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers. World J Hepatol 2025; 17(2): 101165
URL: https://www.wjgnet.com/1948-5182/full/v17/i2/101165.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i2.101165